Track the ImageneBio, Inc. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €60.7m. The latest transaction was filed on 17 August 2026 (Attribution). Among the most active insiders: Yarema Kristin. The full history is accessible without an account.
17
Insider Decl.
n/a
Thresholds
€81,251
1 ops.
Buy Volume
€15,127
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate ImageneBio, Inc. Buy (bullish), based on 3 analysts. Average price target: US$18.00.
28Σ signal
Buys €81,251€15,127 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.